RxDoctor Payments DataLook up a doctor →

Anuradha Thirumalai

Family · Las Vegas, NVNPI 1306217534

Payments from drug & device makers

$18,257in general payments, 2019–2025

Across 841 payments — averaging $21.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Biogen$2K
  • UCB, Inc.$1K
  • Acadia Pharmaceuticals Inc$1K
  • Novartis$1K
  • Genentech USA, Inc.$796
  • plus $10K from 53 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)145$2,568
Biogen74$1,525
UCB, Inc.43$1,383
Acadia Pharmaceuticals Inc62$1,232
Novartis93$1,088
Genentech USA, Inc.30$796
SK Life Science, Inc.27$696
Eisai Inc.37$684
Argenx US, Inc.20$674
EMD Serono, Inc.22$672
Lilly USA, LLC21$552
Lundbeck LLC27$539
Neurocrine Biosciences, Inc.15$516
Amgen23$412
Johnson & Johnson(2 entities)9$382
Bristol Myers Squibb25$368
Corium, LLC12$339
Otsuka America Pharmaceutical, Inc.16$320
Teva Pharmaceuticals USA, Inc.20$259
ANI Pharmaceuticals, Inc.11$252
Takeda Pharmaceuticals U.S.A., Inc.5$219
TG Therapeutics, Inc.5$213
Neurelis, Inc.9$196
Janssen Scientific Affairs, LLC2$192
Pfizer10$189
Ipsen Biopharmaceuticals, Inc3$181
Sanofi8$180
Harmony Biosciences LLC4$136
AstraZeneca(2 entities)7$131
Revance Therapeutics, Inc.2$119
Sumitomo Pharma America, Inc.4$103
Springworks Therapeutics, Inc.4$91
Banner Life Sciences, LLC4$88
Catalyst Pharmaceuticals, Inc.3$76
Grifols USA, LLC3$73
Livanova USA, Inc.2$65
Jazz Pharmaceuticals Inc.2$64
Alnylam Pharmaceuticals Inc.3$61
Sunovion Pharmaceuticals Inc.3$59
Biohaven Pharmaceuticals, Inc.3$53
Biohaven Pharmaceutical Holding Company Ltd.2$52
Tanabe Pharma America, Inc.2$44
Amneal Pharmaceuticals LLC2$43
Avanir Pharmaceuticals, Inc.2$37
Averitas Pharma Inc.1$33
Avadel CNS Pharmaceuticals, LLC1$29
Abbott1$26
Mallinckrodt Hospital Products Inc.1$25
Acorda Therapeutics, Inc1$25
Aurinia Pharma U.S., Inc.1$24
Kyowa Kirin, Inc.1$22
Impel Pharmaceuticals Inc.1$22
Scilex Pharmaceuticals Inc.1$21
Electromed, Inc.1$21
Immedica Pharma US, Inc.1$19
Sandoz1$17
Vanda Pharmaceuticals Inc.1$17
Upsher-smith Laboratories LLC1$16
Axsome Therapeutics, Inc.1$16

How this compares

$18,257 in reported general payments places this provider in the 95th percentile of 1,501 family providers in Nevada.

See all family providers in Nevada →

Medicare billing

Part B allowed, 2024
$56,970
Medicare patients
285
Services billed
818

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Las Vegas

See the full list for Nevada →

Where these figures come from

Is this you, or does something look wrong? →